Crowdonomics
Quadrant Biosciences

Reg CF · Convertible Note · Oct 2020

ClosedReached targetReg CFConvertible Note
via WeFunderView campaign
Raised
$416.6K / $1.1M max
39% of ceiling · target hit day 37
Investors
—
—
Valuation
—
—

Raised over time

Cumulative raisedInvestors
$360K$180K$0
2591300
Oct 12, 2020 · openedFeb 18, 2021 · last reading
Target ($50K) hit — Nov 18, 2020, day 37Deadline Feb 21, 2021 — 3 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2018–FY2019 · hover for source
$414K
FY2018
$414K
−$7.3M
FY2019
RevenueNet income
Metric
FY2018 reviewed*
FY2019 audited
Income statement
Revenue
$413,811
$413,811
Cost of goods sold
$192,281
$426,512
Gross margin
54%
-3%
Net income
$0
-$7,296,264
Taxes paid
-$237,516
$0
Balance sheet
Cash
$1,289,474
$1,289,474
Accounts receivable
$12,653
$12,653
Total assets
$9,091,991
$8,672,233
Short-term debt
$650,959
$736,722
Long-term debt
$5,398,139
$5,349,064
Total liabilities
$5,947,496
$6,085,786
Other
Headcount
42
42

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Oct 8, 2020
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Conversion discount20%
Interest rate6%

Offering details

Target$50,000
Max$1,070,000
Min investment$100
OpenedOct 12, 2020
DeadlineFeb 21, 2021
ClosedFeb 18, 2021
Days active129

Links & provenance

Source: Manual
0001104659-20-098409

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.